Enhanced striatal opioid receptor-mediated G-protein activation in L-dopa-treated dyskinetic monkeys

Neuroscience

Volumn 132, Issue 2, 2005, Pages 409-420

  Chen, L ^a   Togasaki, D M ^a   Langston, J W ^a   Di Monte, D A ^a   Quik, M ^a  

^a PARKINSON S INSTITUTE   (United States)

Author keywords

Autoradiograph; Motor complication; Opioid receptor G protein coupling; Parkinson's disease; Primate model

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; 4 [ALPHA (4 ALLYL 2,5 DIMETHYL 1 PIPERAZINYL) 3 METHOXYBENZYL] N,N DIETHYLBENZAMIDE; DELTA OPIATE RECEPTOR AGONIST; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); KAPPA OPIATE RECEPTOR AGONIST; LEVODOPA; MU OPIATE RECEPTOR AGONIST; OPIATE RECEPTOR; SULFUR 35;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BASAL GANGLION; BRAIN CORTEX; BRAIN REGION; CHEMICAL LABELING; CONTROLLED STUDY; CORPUS STRIATUM; CORRELATION ANALYSIS; DYSKINESIA; INTRACELLULAR SPACE; MONKEY; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

EID: 15744369595     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2004.10.026     Document Type: Article

References (61)

1. G.K. Aghajanian, Y.Y. Wang Pertussis toxin blocks the outward currents evoked by opiate and alpha 2-agonists in locus coeruleus neurons Brain Res 371 1986 390 394
2. J.E. Ahlskog, M.D. Muenter Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature Mov Disord 16 2001 448 458
3. E. Bezard, J.M. Brotchie, C.E. Gross Pathophysiology of levodopa-induced dyskinesia potential for new therapies Nat Rev Neurosci 2 2001 577 588
4. T. Boraud, E. Bezard, B. Bioulac, C.E. Gross Dopamine agonist-induced dyskinesias are correlated to both firing pattern and frequency alterations of pallidal neurones in the MPTP-treated monkey Brain 124 2001 546 557
5. J.M. Brotchie Adjuncts to dopamine replacement a pragmatic approach to reducing the problem of dyskinesia in Parkinson's disease Mov Disord 13 1998 871 876
6. F. Calon, R. Grondin, M. Morissette, M. Goulet, P.J. Blanchet, T. Di Paolo, P.J. Bedard Molecular basis of levodopa-induced dyskinesias Ann Neurol 47 2000 S70 S78
7. M.A. Cenci, C.S. Lee, A. Bjorklund l-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA Eur J Neurosci 10 1998 2694 2706
8. L. Chen, Y. Gu, L.Y. Huang The opioid peptide dynorphin directly blocks NMDA receptor channels in the rat J Physiol 482 Pt 3 1995 575 581
9. L. Chen, L.Y. Huang Sustained potentiation of NMDA receptor-mediated glutamate responses through activation of protein kinase C by a mu opioid Neuron 7 1991 319 326
10. J.B. Daunais, S.R. Letchworth, L.J. Sim-Selley, H.R. Smith, S.R. Childers, L.J. Porrino Functional and anatomical localization of mu opioid receptors in the striatum, amygdala, and extended amygdala of the nonhuman primate J Comp Neurol 433 2001 471 485
11. D.A. Di Monte, A. McCormack, G. Petzinger, A.M. Janson, M. Quik, W.J. Langston Relationship among nigrostriatal denervation, parkinsonism, and dyskinesias in the MPTP primate model Mov Disord 15 2000 459 466
12. R. Emmers, K. Akert A stereotaxic atlas of the brain of the squirrel monkey (Saimiri sciureus) 1963 University of Wisconsin Press Madison, WI
13. J.M. Fearnley, A.J. Lees Ageing and Parkinson's disease substantia nigra regional selectivity Brain 114 Pt 5 1991 2283 2301
14. S. Fox, M. Silverdale, M. Kellett, R. Davies, M. Steiger, N. Fletcher, A. Crossman, J. Brotchie Non-subtype-selective opioid receptor antagonism in treatment of levodopa-induced motor complications in Parkinson's disease Mov Disord 19 2004 554 560
15. C.R. Gerfen, T.M. Engber Molecular neuroanatomic mechanisms of Parkinson's disease a proposed therapeutic approach Neurol Clin 10 1992 435 449
16. W.R. Gibb, J.M. Fearnley, A.J. Lees The anatomy and pigmentation of the human substantia nigra in relation to selective neuronal vulnerability Adv Neurol 53 1990 31 34
17. S. Haber, R. Elde The distribution of enkephalin immunoreactive fibers and terminals in the monkey central nervous system an immunohistochemical study Neuroscience 7 1982 1049 1095
18. S. Haber, R. Elde The distribution of enkephalin immunoreactive neuronal cell bodies in the monkey brain preliminary observations Neurosci Lett 32 1982 247 252
19. S.N. Haber, J.L. Fudge, N.R. McFarland Striatonigrostriatal pathways in primates form an ascending spiral from the shell to the dorsolateral striatum J Neurosci 20 2000 2369 2382
20. B. Henry, A.R. Crossman, J.M. Brotchie Effect of repeated l-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat Exp Neurol 155 1999 204 220
21. B. Henry, S.H. Fox, A.R. Crossman, J.M. Brotchie Mu- and delta-opioid receptor antagonists reduce levodopa-induced dyskinesia in the MPTP-lesioned primate model of Parkinson's disease Exp Neurol 171 2001 139 146
22. M.T. Herrero, S.J. Augood, E.C. Hirsch, F. Javoy-Agid, M.R. Luquin, Y. Agid, J.A. Obeso, P.C. Emson Effects of l-DOPA on preproenkephalin and preprotachykinin gene expression in the MPTP-treated monkey striatum Neuroscience 68 1995 1189 1198
23. Z.G. Jiang, R.A. North Pre- and postsynaptic inhibition by opioids in rat striatum J Neurosci 12 1992 356 361
24. P.A. Johansson, M. Andersson, K.E. Andersson, M.A. Cenci Alterations in cortical and basal ganglia levels of opioid receptor binding in a rat model of l-DOPA-induced dyskinesia Neurobiol Dis 8 2001 220 239
25. S.W. Johnson, R.A. North Opioids excite dopamine neurons by hyperpolarization of local interneurons J Neurosci 12 1992 483 488
26. J. Jolkkonen, P. Jenner, C.D. Marsden l-DOPA reverses altered gene expression of substance P but not enkephalin in the caudate-putamen of common marmosets treated with MPTP Brain Res Mol Brain Res 32 1995 297 307
27. R. Klintenberg, P. Svenningsson, L. Gunne, P.E. Andren Naloxone reduces levodopa-induced dyskinesias and apomorphine-induced rotations in primate models of parkinsonism J Neural Transm 109 2002 1295 1307
28. H. Kurose, T. Katada, T. Amano, M. Ui Specific uncoupling by islet-activating protein, pertussis toxin, of negative signal transduction via alpha-adrenergic, cholinergic, and opiate receptors in neuroblastoma x glioma hybrid cells J Biol Chem 258 1983 4870 4875
29. J.W. Langston, M. Quik, G. Petzinger, M. Jakowec, D.A. Di Monte Investigating levodopa-induced dyskinesias in the parkinsonian primate Ann Neurol 47 2000 S79 S89
30. A. Mansour, M.T. Hoversten, L.P. Taylor, S.J. Watson, H. Akil The cloned mu, delta and kappa receptors and their endogenous ligands evidence for two opioid peptide recognition cores Brain Res 700 1995 89 98
31. A. Mansour, H. Khachaturian, M.E. Lewis, H. Akil, S.J. Watson Anatomy of CNS opioid receptors Trends Neurosci 11 1988 308 314
32. A. Mansour, R.C. Thompson, H. Akil, S.J. Watson Delta opioid receptor mRNA distribution in the brain comparison to delta receptor binding and proenkephalin mRNA J Chem Neuroanat 6 1993 351 362
33. C. Missale, S.R. Nash, S.W. Robinson, M. Jaber, M.G. Caron Dopamine receptors from structure to function Physiol Rev 78 1998 189 225
34. M. Morissette, M. Goulet, J.J. Soghomonian, P.J. Blanchet, F. Calon, P.J. Bedard, T. Di Paolo Preproenkephalin mRNA expression in the caudate-putamen of MPTP monkeys after chronic treatment with the D2 agonist U91356A in continuous or intermittent mode of administration comparison with l-DOPA therapy Brain Res Mol Brain Res 49 1997 55 62
35. M. Morissette, R. Grondin, M. Goulet, P.J. Bedard, T. Di Paolo Differential regulation of striatal preproenkephalin and preprotachykinin mRNA levels in MPTP-lesioned monkeys chronically treated with dopamine D1 or D2 receptor agonists J Neurochem 72 1999 682 692
36. A. Neil, L. Terenius, J.W. Ternes, R.N. Ehrman, C.P. O'Brien Opiate receptors, neuropeptides in CNS and CSF of two Macaca species with different responsiveness to opiates Eur J Pharmacol 122 1986 143 147
37. S.M. Papa, R. Desimone, M. Fiorani, E.H. Oldfield Internal globus pallidus discharge is nearly suppressed during levodopa-induced dyskinesias Ann Neurol 46 1999 732 738
38. A. Parent, M.C. Asselin, P.Y. Cote Dopaminergic regulation of peptide gene expression in the striatum of normal and parkinsonian monkeys Adv Neurol 69 1996 73 77
39. A. Parent, B. Lavoie The heterogeneity of the mesostriatal dopaminergic system as revealed in normal and parkinsonian monkeys Adv Neurol 60 1993 25 33
40. A. Parent, A. Mackey, Y. Smith, R. Boucher The output organization of the substantia nigra in primate as revealed by a retrograde double labeling method Brain Res Bull 10 1983 529 537
41. R.K. Pearce, M. Heikkila, I.B. Linden, P. Jenner l-dopa induces dyskinesia in normal monkeys behavioural and pharmacokinetic observations Psychopharmacology (Berl) 156 2001 402 409
42. A. Pfeiffer, A. Herz Discrimination of three opiate receptor binding sites with the use of a computerized curve-fitting technique Mol Pharmacol 21 1982 266 271
43. A. Pfeiffer, A. Pasi, P. Mehraein, A. Herz Opiate receptor binding sites in human brain Brain Res 248 1982 87 96
44. B. Picconi, D. Centonze, K. Hakansson, G. Bernardi, P. Greengard, G. Fisone, M.A. Cenci, P. Calabresi Loss of bidirectional striatal synaptic plasticity in l-DOPA-induced dyskinesia Nat Neurosci 6 2003 501 506
45. L.J. Porrino, J.J. Viola, A.M. Crane, F.E. Pontieri Alterations in opiate receptor binding in MPTP-induced hemiparkinsonian monkeys Neurosci Lett 127 1991 155 159
46. M. Quik, S. Police, J.W. Langston, D.A. Di Monte Increases in striatal preproenkephalin gene expression are associated with nigrostriatal damage but not l-DOPA-induced dyskinesias in the squirrel monkey Neuroscience 113 2002 213 220
47. P. Samadi, L. Gregoire, P.J. Bedard Opioid antagonists increase the dyskinetic response to dopaminergic agents in parkinsonian monkeys interaction between dopamine and opioid systems Neuropharmacology 45 2003 954 963
48. J.S. Schneider, E. Decamp, T. Wade Striatal preproenkephalin gene expression is upregulated in acute but not chronic parkinsonian monkeys implications for the contribution of the indirect striatopallidal circuit to parkinsonian symptomatology J Neurosci 19 1999 6643 6649
49. D.E. Selley, J.M. Bidlack Effects of beta-endorphin on mu and delta opioid receptor-coupled G-protein activity low-Km GTPase studies J Pharmacol Exp Ther 263 1992 99 104
50. 35S]guanylyl-5′- O-(gamma-thio)-triphosphate binding in guinea pig brain J Comp Neurol 386 1997 562 572
51. 35S]thio]-triphosphate binding Proc Natl Acad Sci USA 92 1995 7242 7246
52. 35S] GTPgammaS autoradiography in rat brain J Neurosci 16 1996 2684 2692
53. L.J. Sim, D.E. Selley, R. Xiao, S.R. Childers Differences in G-protein activation by mu- and delta-opioid, and cannabinoid, receptors in rat striatum Eur J Pharmacol 307 1996 97 105
54. 35S]guanylyl-5′-O-(gamma-thio)-triphosphate binding in cynomolgus monkey brain Neuroscience 94 1999 651 662
55. L.A. Smith, B.C. Tel, M.J. Jackson, M.J. Hansard, R. Braceras, C. Bonhomme, C. Chezaubernard, S. Del Signore, S. Rose, P. Jenner Repeated administration of piribedil induces less dyskinesia than l-dopa in MPTP-treated common marmosets a behavioural and biochemical investigation Mov Disord 17 2002 887 901
56. J.C. Stoof, J.W. Kebabian Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum Nature 294 1981 366 368
57. L.C. Tan, P.H. Protell, J.W. Langston, D.M. Togasaki The hyperkinetic abnormal movements scale a tool for measuring levodopa-induced abnormal movements in squirrel monkeys Mov Disord 17 2002 902 909
58. D.M. Togasaki, L. Tan, P. Protell, D.A. Di Monte, M. Quik, J.W. Langston Levodopa induces dyskinesias in normal squirrel monkeys Ann Neurol 50 2001 254 257
59. E.M. Unterwald, M. Cuntapay Dopamine-opioid interactions in the rat striatum a modulatory role for dopamine D1 receptors in delta opioid receptor-mediated signal transduction Neuropharmacology 39 2000 372 381
60. P. Voorn, L.S. Brady, H.W. Berendse, E.K. Richfield Densitometrical analysis of opioid receptor ligand binding in the human striatum: I. Distribution of mu opioid receptor defines shell and core of the ventral striatum Neuroscience 75 1996 777 792
61. B.Y. Zeng, R.K. Pearce, G.M. MacKenzie, P. Jenner Alterations in preproenkephalin and adenosine-2a receptor mRNA, but not preprotachykinin mRNA correlate with occurrence of dyskinesia in normal monkeys chronically treated with l-DOPA Eur J Neurosci 12 2000 1096 1104